Latest Kansas Bioscience Authority Stories
Leading pharmaceutical and biotech companies outsource more than $1 billion in drug development research to area organizations CHICAGO, June 21, 2011 /PRNewswire-USNewswire/ -- According to a new study released today at the annual meeting of the Drug Information Association in Chicago, the greater Kansas City region is home to a significant cluster of contract research organizations (CROs) and contract service providers (CSPs), with more than $1 billion in annual revenue.
UNION CITY, Calif., May 11, 2011 /PRNewswire/ -- Abaxis, Inc.
OLATHE, Kan. Oct.
$11 Million in New Projects Approved in Atlanta ATLANTA, May 19 /PRNewswire-USNewswire/ -- Meeting at the world's largest bioscience and biotechnology convention, the Kansas Bioscience Authority has approved more than $11 million in new investments as part of a $581 million initiative to help researchers and businesses thrive in the state. The funding decisions made at the Bio International Convention will create bioscience centers of innovation in biomaterials and plant biology, expand...
SAN DIEGO, June 18 /PRNewswire/ -- Kansas researchers and companies excel in the human health biosciences, and $3.7 million in new Kansas Bioscience Authority (KBA) investments in that sector will support cutting-edge innovations for the treatment of cancer, HIV, and osteoporosis, as well as in pharmaceutical development.